Z-1674-2014 Class II Terminated
FDA device recall Z-1674-2014 was initiated by CryoLife, Inc. on Apr 25, 2014 and is designated Class II. Reason for recall: Serum albumin component monomer failed to meet internally established end of shelf-life specification. The recall status is terminated (terminated Nov 10, 2014). Affected quantity: 6190 units.
Recall details
- Product Type
- Devices
- Report Date
- Jun 11, 2014
- Initiation Date
- Apr 25, 2014
- Termination Date
- Nov 10, 2014
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 6190 units
Product description
Reason for recall
Distribution pattern
Distributed Nationwide including Puerto Rico and the states of AL, AK,AZ, AR, CA, CO, CT, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, MD, MA, MI, MN, MS, MO, MT, NV, NH, NJ, NM , NY, NC, ND, OH, OK, OR, PA, SC, SD, TN, TX, UT, VA, WA, WV, and WI.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1674-2014
- openFDA file date
- Nov 19, 2026
- Loaded by RegDataLab
- Nov 20, 2026
Need the full FDA record for CryoLife, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.